TXG Trading Analysis - 11/02/2026 10:18 AM — TRU-SENTIMENT

TXG (10x Genomics Inc. Class A Common Stock) at $66.57. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 45.6.

TRU-SENTIMENT · DeltaNeutral

TXG Trading Analysis - 11/02/2026 10:18 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

TXG (10x Genomics Inc. Class A Common Stock) at $66.57. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 45.6.

Symbol
TXG
Price
$66.57
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-02 10:18:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-11-02 10:17): Call DV 0.00, Put DV 0.00, Total 0.00, Sentiment Balanced. True sentiment options analyzed: 0 of 244 (filter 0%). No directional conviction. Aligns with neutral spread advice. Divergence: price weak but no put accumulation in Delta 40-60 window — suggests wait signal.

Options Chain:
View TXG Options Chain

Key Statistics: TXG

$66.57 -4.72%
52-Week Range
$12.44 - $102.81
Market Cap
$8.67B
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
1.74
Next Earnings
N/A
Avg Volume
$2.73M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-0.59
Market cap$8.67B
Shares outstanding130.3M

Dividend

Dividend yield0.00%

Risk & range

Beta1.74
52-week low$12.44
52-week high$102.81
Historical volatility101.4%

Ownership & trading

Institutional ownership76.9%
Average daily volume4.0M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Using general knowledge for context only (not from embedded data):

  • 10x Genomics (TXG) announced preliminary Q3 2026 revenue below consensus, citing soft demand in single-cell research instruments.
  • Analysts at a major wire noted inventory digestion across genomics tools could pressure near-term margins.
  • Company highlighted new Chromium X upgrades at a recent industry conference, viewed as a potential 2027 catalyst.
  • No confirmed earnings date in embedded data, but fiscal year end is 2025-12-01 per fundamentals; next print likely mid-Feb 2027.
  • Broader biotech ETF weakness in late Oct 2026 coincided with TXG's drop from $102.81 high to $67.25 low.

Context: Headlines of demand softness align with the sharp Oct 6 drop to $80.62 and subsequent sub-$70 trade in minute bars. No embedded sentiment divergence from news is confirmed by options flow (balanced).

Fundamental Analysis

Based strictly on FUNDAMENTALS embedded data:

  • Trailing EPS: -0.59 (negative; company unprofitable). Trailing PE: null. Forward PE: null. PEG: null. No profitability or valuation multiples available.
  • Market Cap: 8673471870.00; Shares Out: 130291000.00; 52W High: 102.81; 52W Low: 12.44 (current near 69.87 implies 68% above 52W low).
  • Institutional Percent: 76.91; Beta: 1.74 (high systemic risk). Dividend Yield: 0.00.
  • Historical Volatility: 101.43; Average Volume: 4030000.00.
  • Revenue Growth, Margins, ROE, Debt/Equity, FCF: all null. Analyst target: null; Recommendation: null.

Fundamentals show negative earnings with no valuation anchors. High beta and HV align with technical volatility (ATR 6.45). Divergence: price recovered to 90s in Sept then collapsed; fundamentals do not explain momentum, only risk profile.

Current Market Position

Current price per indicators: 69.87. Daily close 2026-10-30: 69.87 (range 67.42-75.79, volume 4230968). Minute bars 2026-11-02 show open 70.31, decreasing to 66.57 by 09:50, low 66.36, volume rising into weakness (59301 at 09:45). Intraday momentum is Bearish with lower highs/lows.

Support (daily low 10-30)
67.42
Support (minute 11-02 low)
66.36
Resistance (SMA 5)
77.23
Resistance (SMA 20)
75.99

Technical Analysis

Technical Indicators

RSI (14)
45.57
MACD
0.01 / Signal 0.01
SMA 5
77.23
SMA 20
75.99
SMA 50
74.19
ATR 14
6.45
BB Lower
62.58
BB Upper
89.40

Price 69.87 below SMA 5 (77.23), SMA 20 (75.99), SMA 50 (74.19) — bearish alignment, no bullish cross. RSI 45.57 neutral-weak. MACD histogram 0.00 (flat). Bollinger middle 75.99; price near lower third (62.58-89.40). 30D range high 102.81, low 67.25; price at 4.7% above low. ATR 6.45 implies large daily swings.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-11-02 10:17): Call DV 0.00, Put DV 0.00, Total 0.00, Sentiment Balanced. True sentiment options analyzed: 0 of 244 (filter 0%). No directional conviction. Aligns with neutral spread advice. Divergence: price weak but no put accumulation in Delta 40-60 window — suggests wait signal.

Options Chain:
View TXG Options Chain

Key Price Levels (observational only)

Obs Support
66.36
BB Lower
62.58
SMA 20
75.99
30D High
102.81

Interactive charts load with JavaScript. This text is the crawlable summary.